Biochem/physiol Actions
Cell permeable: no
Reversible: no
Primary Targetcathepsin B
Product does not compete with ATP.
k2/Ki = 1 x 104 M-1 sec-1
General description
Cysteine protease inhibitor. Selectively inhibits cathepsin B (k2/Ki = 1 x 104 M-1 sec-1), cathepsin L (k2/Ki = 1.5 x 105 M-1 sec-1), cathepsin S (k2/Ki = 6.6 x 104 M-1 sec-1), and papain (k2/Ki = 1 x 103 M-1 sec-1).
Half-life in buffered solution (pH 5-9) = 37 h (30°C); 300 h (0°C).
Cysteine protease inhibitor. Selectively inhibits cathepsin B (k2/Ki = 1.0 x 104 M-1sec-1), cathepsin L (k2/Ki = 1.5 x 105 M-1sec-1), cathepsin S (k2/Ki = 6.6 x 104 M-1sec-1), and papain (k2/Ki = 1.0 x 103 M-1sec-1). Half-life in buffered solution (pH 5-9) = 37 h (30°C); 300 h (0°C).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Demuth, H.-U., et al. 1996. Biochim. Biophys. Acta1295, 179.Brömme, D., and Demuth, H.-U. 1994. Methods Enzymol. 244, 671.
Packaging
1 mg in Plastic ampoule
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Sequence
Z-Phe-Gly-NHO-Bz-pOMe
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: